Trupanion Raises Full-Year Guidance But Signals H2 Deceleration as Veterinary Visit Decline Weighs on Growth

By
Stonehaven Analytics
/
Aug 11, 2026

Trupanion has modestly raised its full-year 2026 guidance to $1.584–$1.601 billion in total revenue while simultaneously signalling a slowdown in the second half of the year, with Q3 subscription revenue growth forecast at 13% — down from the 14% full-year rate — and adjusted operating income growth decelerating sharply from 19% annually to 11% in Q3, as declining veterinary visit volumes create headwinds across the pet health sector.

Trupanion’s Q2 2026 earnings call delivered a nuanced message to investors: the pet insurance group is performing ahead of prior expectations on a full-year basis, but the second half outlook is more measured than the headline guidance number suggests.

Full-year 2026 guidance points to subscription revenue growth of 14% year-on-year and adjusted operating income growth of 19%, with total revenue of $1.584–$1.601 billion — a slight upgrade on prior guidance. CEO Margi Tooth confirmed the second half is off to a solid start.

However, Q3 guidance tells a more cautious story. Subscription revenue growth is expected to moderate to 13% at the midpoint, while adjusted operating income growth slows substantially to 11%, with total Q3 revenue of $399–$405 million. The deceleration in operating income growth is the most significant signal, reflecting strategic investment in pet acquisition, technology and shareholder returns alongside industry-wide headwinds.
The backdrop is familiar across the sector. A downturn in new veterinary visits — the same dynamic pressuring Zoetis’s US companion animal business — is reducing the touchpoints at which pet owners discover and adopt insurance products. Trupanion is also deploying expanded deductible and coinsurance product options throughout the remainder of the year, with the rollout timing introducing near-term uncertainty.

CFO Fawwad Qureshi emphasised disciplined execution alongside meaningful capital deployment, signalling confidence in the long-term trajectory even as short-term growth rates temper.

"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."

Scroll to Top